Uptake of Novel Medical Therapies in the General Population
1
Division of Cancer Care and Epidemiology, Queen’s University Cancer Research Institute, Kingston, ON K7L 3N6, Canada
2
Medical Oncology Centre of Rosebank, Johannesburg, South Africa
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2011, 18(3), 105-108; https://doi.org/10.3747/co.v18i3.858
Submission received: 4 March 2011
/
Revised: 3 April 2011
/
Accepted: 2 May 2011
/
Published: 1 June 2011
Abstract
The randomized controlled trial (rct) remains the “gold standard” for establishing the efficacy of new medical therapies [...]
Keywords:
outcomes research; health services; breast cancer; chemotherapy; supportive care
Share and Cite
MDPI and ACS Style
Booth, C.M.; Rapoport, B. Uptake of Novel Medical Therapies in the General Population. Curr. Oncol. 2011, 18, 105-108. https://doi.org/10.3747/co.v18i3.858
AMA Style
Booth CM, Rapoport B. Uptake of Novel Medical Therapies in the General Population. Current Oncology. 2011; 18(3):105-108. https://doi.org/10.3747/co.v18i3.858
Chicago/Turabian StyleBooth, C.M., and B. Rapoport. 2011. "Uptake of Novel Medical Therapies in the General Population" Current Oncology 18, no. 3: 105-108. https://doi.org/10.3747/co.v18i3.858
